Pre-eclampsia and the risk of retinopathy of prematurity in preterm infants with birth weight <1500 g and/or <31 weeks' gestation
- PMID: 29354703
- PMCID: PMC5721629
- DOI: 10.1136/bmjophth-2016-000049
Pre-eclampsia and the risk of retinopathy of prematurity in preterm infants with birth weight <1500 g and/or <31 weeks' gestation
Abstract
Objective: To evaluate the relationship between pre-eclampsia and development of retinopathy of prematurity (ROP) in infants with birth weight of <1500 g and/or gestation <31 weeks.
Methods: A retrospective cohort study comprising infants born to mothers with pre-eclampsia between January 2007 and June 2010 at a single tertiary care centre. Their ROP outcome was compared with infants born to the next two normotensive mothers with a ±1 week gestational age difference. Pearson χ2 test was used for categorical variables and Mann-Whitney U test was used for continuous variables. Multivariable regression was used to estimate the OR of ROP with prenatal pre-eclampsia exposure and adjust for confounders.
Results: Of the 97 infants in the pre-eclampsia group, 27 (27%) developed ROP and of the 185 infants in the normotensive group, 50 (27%) developed ROP. On multivariable regression modelling, pre-eclampsia was not a risk factor for the development of ROP (OR 1.4, 95% CI 0.46 to 4.1). Gestational age, intrauterine growth restriction and blood transfusion were significant risk factors for the development of ROP.
Conclusions: In our cohort, pre-eclampsia was not a significant risk factor for the development of ROP. Intrauterine growth restricted infants of pre-eclamptic and normotensive mothers were at higher risk of ROP.
Keywords: Angiogenesis; Epidemiology; Neovascularisation; Retina.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Association of Maternal Preeclampsia With Infant Risk of Premature Birth and Retinopathy of Prematurity.JAMA Ophthalmol. 2017 Sep 1;135(9):947-953. doi: 10.1001/jamaophthalmol.2017.2697. JAMA Ophthalmol. 2017. PMID: 28796851 Free PMC article.
-
Maternal preeclampsia is associated with an increased risk of retinopathy of prematurity.J Perinat Med. 2011 Sep;39(5):523-7. doi: 10.1515/jpm.2011.071. Epub 2011 Aug 31. J Perinat Med. 2011. PMID: 21878037
-
Factors in Premature Infants Associated With Low Risk of Developing Retinopathy of Prematurity.JAMA Ophthalmol. 2019 Feb 1;137(2):160-166. doi: 10.1001/jamaophthalmol.2018.5520. JAMA Ophthalmol. 2019. PMID: 30452500 Free PMC article.
-
Prevalence and Risk Factors of Retinopathy of Prematurity in Iran.J Ophthalmic Vis Res. 2019 Jul 18;14(3):291-298. doi: 10.18502/jovr.v14i3.4785. eCollection 2019 Jul-Sep. J Ophthalmic Vis Res. 2019. PMID: 31660108 Free PMC article. Review.
-
Retinopathy of prematurity in Indonesia: Incidence and risk factors.J Neonatal Perinatal Med. 2017;10(1):85-90. doi: 10.3233/NPM-915142. J Neonatal Perinatal Med. 2017. PMID: 28304327 Review.
Cited by
-
Histological Chorioamnionitis and Funisitis as New Risk Factors for Retinopathy of Prematurity: A Meta-analysis.Am J Perinatol. 2024 May;41(S 01):e3264-e3273. doi: 10.1055/a-2215-0662. Epub 2023 Nov 21. Am J Perinatol. 2024. PMID: 37989252 Free PMC article.
-
Neonatal outcomes of twins <29 weeks gestation of mothers with hypertensive disorders of pregnancy.Pediatr Res. 2022 Sep;92(3):748-753. doi: 10.1038/s41390-022-02044-5. Epub 2022 Apr 5. Pediatr Res. 2022. PMID: 35383262
-
Effect of red blood cell transfusion on the development of retinopathy of prematurity: A systematic review and meta-analysis.PLoS One. 2020 Jun 8;15(6):e0234266. doi: 10.1371/journal.pone.0234266. eCollection 2020. PLoS One. 2020. PMID: 32512582 Free PMC article.
-
Impact of hypertensive disorders of pregnancy on neonatal outcomes among infants born at 24+0-31+6 weeks' gestation in China: A multicenter cohort study.Front Pediatr. 2023 Feb 23;11:1005383. doi: 10.3389/fped.2023.1005383. eCollection 2023. Front Pediatr. 2023. PMID: 36911015 Free PMC article.
References
-
- Holmström G, Larsson E. Outcome of retinopathy of prematurity. Clin Perinatol 2013;40:311–21. doi:10.1016/j.clp.2013.02.008 - DOI - PubMed
-
- Hartnett ME, Penn JS. Mechanisms and management of retinopathy of prematurity. N Engl J Med 2012;367:2515–26. doi:10.1056/NEJMra1208129 - DOI - PMC - PubMed
-
- Slidsborg C, Olesen HB, Jensen PK, et al. . Treatment for retinopathy of prematurity in Denmark in a ten-year period (1996–2005): is the incidence increasing? Pediatrics 2008;121:97–105. doi:10.1542/peds.2007-0644 - DOI - PubMed
-
- Smith LE, Hard AL, Hellström A. The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment. Clin Perinatol 2013;40:201–14. doi:10.1016/j.clp.2013.02.002 - DOI - PMC - PubMed
-
- Pratt A, Da Silva Costa F, Borg AJ, et al. . Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia. Angiogenesis 2015;18:115–23. doi:10.1007/s10456-014-9452-3 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources